BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10332701)

  • 1. An interaction between digoxin and acarbose.
    Ben-Ami H; Krivoy N; Nagachandran P; Roguin A; Edoute Y
    Diabetes Care; 1999 May; 22(5):860-1. PubMed ID: 10332701
    [No Abstract]   [Full Text] [Related]  

  • 2. A possible interaction of potential clinical interest between digoxin and acarbose.
    Serrano JS; Jiménez CM; Serrano MI; Balboa B
    Clin Pharmacol Ther; 1996 Nov; 60(5):589-92. PubMed ID: 8941033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are there different effects of acarbose and voglibose on serum levels of digoxin in a diabetic patient with congestive heart failure?
    Nagai Y; Hayakawa T; Abe T; Nomura G
    Diabetes Care; 2000 Nov; 23(11):1703. PubMed ID: 11092296
    [No Abstract]   [Full Text] [Related]  

  • 4. [The use of acarbose for treating diabetic patients].
    Balabolkin MI; Dedov II; Mkrtumian AM; Ametov AS; Kakhnovskiĭ IM; Chazova TE; Koroleva TS; Kochergina II; Matveeva LS
    Ter Arkh; 1994; 66(10):20-1. PubMed ID: 7863437
    [No Abstract]   [Full Text] [Related]  

  • 5. [Oral antidiabetics: acarbose].
    Taurand S
    Soins; 1996 May; (606):61-2. PubMed ID: 8717785
    [No Abstract]   [Full Text] [Related]  

  • 6. [Insulin, glibenclamide plus acarbose in diabetes mellitus?].
    Hauner H
    Dtsch Med Wochenschr; 1995 Nov; 120(46):1605. PubMed ID: 7588044
    [No Abstract]   [Full Text] [Related]  

  • 7. Acarbose in the treatment of type I diabetes.
    Hollander P; Pi-Sunyer X; Coniff RF
    Diabetes Care; 1997 Mar; 20(3):248-53. PubMed ID: 9051366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acarbose and insulin dependent diabetes, type 1].
    Gabriel Botella F; Galindo Puerto MJ
    An Med Interna; 1996 Dec; 13(12):618. PubMed ID: 9063950
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of acarbose in the primary-care setting: evaluation of efficacy and tolerability of acarbose by postmarketing surveillance study.
    Spengler M; Cagatay M
    Clin Invest Med; 1995 Aug; 18(4):325-31. PubMed ID: 8549020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acarbose and insulin therapy in type I diabetes mellitus.
    Rios MS
    Eur J Clin Invest; 1994 Aug; 24 Suppl 3():36-9. PubMed ID: 8001626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acarbose: in search for its real indications in current medical practice.
    Lerman I; Gómez Perez FJ; Aguilar-Salinas CA; Rodrigo JA
    Diabetes Care; 1996 Jan; 19(1):94-5. PubMed ID: 8720547
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of acarbose (Glucobay) in persons with type 1 diabetes: a multicentre study.
    Sels JP; Verdonk HE; Wolffenbuttel BH
    Diabetes Res Clin Pract; 1998 Aug; 41(2):139-45. PubMed ID: 9789720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind crossover study of acarbose in type 1 diabetic patients.
    Marena S; Tagliaferro V; Cavallero G; Pagani A; Montegrosso G; Bianchi W; Zaccarini P; Pagano G
    Diabet Med; 1991; 8(7):674-8. PubMed ID: 1833121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of long term acarbose (Bay g 5421) therapy on metabolic control of non insulin dependent (type II) diabetes mellitus.
    Rodier M; Richard JL; Monnier L; Mirouze J
    Diabete Metab; 1988; 14(1):12-4. PubMed ID: 3292303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential response of plasma lipoprotein(a) and apolipoprotein B in NIDDM subjects treated with acarbose.
    Hegele RA; Connelly PW; Palmason C; Jenkins DJ; Wolever TM
    Diabetes Care; 1995 Feb; 18(2):272-3. PubMed ID: 7729310
    [No Abstract]   [Full Text] [Related]  

  • 16. New agents available for the treatment of diabetes.
    Miller EC
    Home Care Provid; 1996; 1(6):312-4. PubMed ID: 9188302
    [No Abstract]   [Full Text] [Related]  

  • 17. Polypharmacy in the Elderly-When Good Drugs Lead to Bad Outcomes: A Teachable Moment.
    Carroll C; Hassanin A
    JAMA Intern Med; 2017 Jun; 177(6):871. PubMed ID: 28437544
    [No Abstract]   [Full Text] [Related]  

  • 18. A double-blind placebo-controlled trial evaluating the safety and efficacy of acarbose for the treatment of patients with insulin-requiring type II diabetes.
    Coniff RF; Shapiro JA; Seaton TB; Hoogwerf BJ; Hunt JA
    Diabetes Care; 1995 Jul; 18(7):928-32. PubMed ID: 7555551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of intestinal alpha glucosidases in the therapy of diabetes mellitus].
    Fölsch UR; Lembcke B
    Internist (Berl); 1991 Dec; 32(12):699-707. PubMed ID: 1823561
    [No Abstract]   [Full Text] [Related]  

  • 20. No relationship between carbohydrate intake and effect of acarbose on HbA1c or gastrointestinal symptoms in type 2 diabetic subjects consuming 30-60% of energy from carbohydrate.
    Wolever TM; Chiasson JL; Josse RG; Hunt JA; Palmason C; Rodger NW; Ross SA; Ryan EA; Tan MH
    Diabetes Care; 1998 Oct; 21(10):1612-8. PubMed ID: 9773719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.